Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Diabetes
•
Male and Female Reproductive Disorders
•
Primary Care
Do you regularly counsel younger women of childbearing age about the impact of Tirzepatide on oral hormonal contraception?
https://pubmed.ncbi.nlm.nih.gov/37940101/
Related Questions
Outside of teplizumab, what therapies do you recommend for preserving beta cell function in patients with early stage type 1 diabetes mellitus?
How long would you hold clomiphene before checking baseline morning testosterone levels to evaluate the need for testosterone replacement therapy initiation?
What is the optimal BP target for patients with diabetes and hypertension to reduce their risk of MI/stroke?
Can rapid weight loss following GLP1 R agonist therapy lead to postprandial hypoglycemia and if so, what are the treatment options outside of dietary modifications?
In a young male patient with hypogonadotropic hypogonadism and fertility goals, would starting testosterone replacement therapy affect fertility chances?
How should we approach the management of PCOS in transgender men seeking virilization?
How has the use of CGMs informed or improved your management of patients with pre diabetes or diabetes not on insulin?
After what time frame off GLP-1 RA therapy should you restart at the lowest starting dose?
Is it safe to prescribe Invokana or Metformin for patients taking Biktarvy?
Do you recommend a trial of Tamoxifen to treat young men with painful unilateral gynecomastia with normal testosterone levels?